Oscar Health, Inc. (NYSE:OSCR - Get Free Report) was the target of some unusual options trading on Tuesday. Stock investors purchased 27,373 call options on the stock. This represents an increase of 303% compared to the typical volume of 6,798 call options.
Wall Street Analysts Forecast Growth
A number of research analysts have issued reports on OSCR shares. Jefferies Financial Group started coverage on Oscar Health in a research report on Tuesday, December 10th. They issued an "underperform" rating and a $12.00 target price on the stock. Bank of America downgraded shares of Oscar Health from a "neutral" rating to an "underperform" rating and dropped their price objective for the company from $21.00 to $13.50 in a research note on Wednesday, November 6th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $21.56.
Check Out Our Latest Report on Oscar Health
Insider Activity at Oscar Health
In other Oscar Health news, EVP Ranmali Bopitiya sold 19,157 shares of the business's stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total transaction of $346,358.56. Following the completion of the transaction, the executive vice president now directly owns 241,488 shares in the company, valued at $4,366,103.04. The trade was a 7.35 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Mario Schlosser sold 6,516 shares of the firm's stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total value of $117,809.28. Following the completion of the sale, the insider now directly owns 81,962 shares in the company, valued at approximately $1,481,872.96. This represents a 7.36 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 78,610 shares of company stock worth $1,421,269. Company insiders own 25.11% of the company's stock.
Institutional Trading of Oscar Health
A number of institutional investors and hedge funds have recently added to or reduced their stakes in OSCR. Creative Planning boosted its stake in shares of Oscar Health by 73.8% in the 3rd quarter. Creative Planning now owns 31,296 shares of the company's stock valued at $664,000 after purchasing an additional 13,286 shares during the last quarter. Allspring Global Investments Holdings LLC grew its holdings in Oscar Health by 1.7% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 109,074 shares of the company's stock worth $2,313,000 after acquiring an additional 1,866 shares during the period. Toth Financial Advisory Corp lifted its stake in shares of Oscar Health by 73,185.7% in the 3rd quarter. Toth Financial Advisory Corp now owns 51,300 shares of the company's stock valued at $1,088,000 after purchasing an additional 51,230 shares during the period. Wealth Enhancement Advisory Services LLC boosted its position in shares of Oscar Health by 7.5% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 12,028 shares of the company's stock valued at $255,000 after purchasing an additional 844 shares in the last quarter. Finally, FCG Investment Co acquired a new stake in Oscar Health during the third quarter worth approximately $986,000. Institutional investors and hedge funds own 75.70% of the company's stock.
Oscar Health Trading Down 7.8 %
NYSE OSCR traded down $1.26 on Friday, hitting $14.81. The company's stock had a trading volume of 6,082,590 shares, compared to its average volume of 4,542,156. The company's 50-day moving average is $14.82 and its 200 day moving average is $16.68. The firm has a market cap of $3.66 billion, a PE ratio of -740.33 and a beta of 1.73. Oscar Health has a 1-year low of $12.43 and a 1-year high of $23.79. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26.
Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. As a group, analysts predict that Oscar Health will post 0.69 earnings per share for the current fiscal year.
Oscar Health Company Profile
(
Get Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Featured Articles
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.